Antibody formats are becoming more elaborate. These next-generation biologics, such as bispecific antibodies, are bringing new challenges to the field of analytical characterization of modern biotherapeutics. Mass spectrometry can be applied to get fast, repeatable and reliable answers.
Lonza scientists have been using native and denaturing intact MS approaches to enable fast chain assembly analysis for IgG-like bispecific molecules in early development. Leveraging key tools from the analytical toolbox (enzymes cleaving at specific sites or allowing full deglycosylation) allows them to accelerate rapid method development and timely implementation supporting efficient delivery of their projects. By choosing Protein Metric’s software utilizing parsimonious charge deconvolution algorithm and the Byos platform functionalities, they can take advantage of their setup for high throughput intact MS allowing fast ranking during expression vector design and clone selection.
This session was recorded in November 2022.